Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Figg

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
Therapeutic Drug Monitoring|December 1, 1996
Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agentsS Boudoulas, R M Lush, N A McCall, et al.
The Annals of Pharmacotherapy|January 1, 1997
Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic targetS C Dixon, B J Soriano, R M Lush, et al.
Seminars in Oncology|December 12, 2001
Approaches to preclinical screening of antiangiogenic agentsE A Kruger, P H Duray, D K Price, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasmaM A Rudek, C L March, K S Bauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathwayK S Bauer, K J Cude, S C Dixon, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patientsS C Piscitelli, W D Figg, B Hahn, et al.
Surgery|February 15, 2001
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancerD L Bartlett, S K Libutti, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factorE J Small, D M Reese, B Um, et al.
Cancer|May 15, 1997
Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinomaW D Figg, G Kroog, P Duray, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
Therapeutic Drug Monitoring|December 1, 1996
Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agentsS Boudoulas, R M Lush, N A McCall, et al.
The Annals of Pharmacotherapy|January 1, 1997
Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic targetS C Dixon, B J Soriano, R M Lush, et al.
Seminars in Oncology|December 12, 2001
Approaches to preclinical screening of antiangiogenic agentsE A Kruger, P H Duray, D K Price, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasmaM A Rudek, C L March, K S Bauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathwayK S Bauer, K J Cude, S C Dixon, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patientsS C Piscitelli, W D Figg, B Hahn, et al.
Surgery|February 15, 2001
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancerD L Bartlett, S K Libutti, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factorE J Small, D M Reese, B Um, et al.
Cancer|May 15, 1997
Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinomaW D Figg, G Kroog, P Duray, et al.
Pageof 14